Characteristics of Selenazolidine Prodrugs of Selenocysteine: Toxicity and Glutathione Peroxidase Induction in V79 Cells
- 17 June 2003
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 46 (15), 3308-3313
- https://doi.org/10.1021/jm020496q
Abstract
Novel selenazolidine prodrugs of selenocysteine are being developed as potential selenium delivery agents for cancer chemoprevention and other clinical uses. The 2-unsubstituted compound, selenazolidine-4(R)-carboxylic acid (l-SCA), and the 2-oxo- and 2-methyl analogues possessing d-stereochemistry (d-OSCA and d-MSCA, respectively) were synthesized and chemically characterized. l/d pairs, along with other organoselenium compounds and common inorganic forms, were studied in cultured V79 cells to understand their inherent toxicity and their ability to induce selenium-dependent glutathione peroxidase (GPx) activity, which indicates the provision of biologically available selenium. All of the selenazolidines were much less toxic to the cells than was sodium selenite (IC50 ≈ 17 μM) or the parent selenolamines, l- or d-selenocystine (IC50 ≈ 34 or 39 μM, respectively); OSCA was less toxic than MSCA. The stereoisomers of OSCA produced very different IC50 values (l-OSCA, ∼451 μM; d-OSCA, >3000 μM), while the IC50 values derived for the stereoisomers of MSCA were of the same order of magnitude (l-MSCA, ∼79 μM; d-MSCA, ∼160 μM). Compounds possessing l-stereochemistry were at least as active with respect to GPx induction as was sodium selenite (2.2-fold increase at 15 μM). l-Selenocystine produced a 4.2-fold increase in GPx activity at 30 μM, while l-SCA produced a 5.9-fold increase, followed by l-OSCA (4.6-fold) and l-MSCA (2.1-fold), all at 100 μM. Compounds possessing d-stereochemistry showed minimal ability to induce GPx activity (d-selenocystine, 1.0-fold increase; d-OSCA, 1.4-fold increase; d-MSCA, 1.3-fold increase).Keywords
This publication has 21 references indexed in Scilit:
- Methylseleninate Is a Substrate Rather Than an Inhibitor of Mammalian Thioredoxin ReductaseJournal of Biological Chemistry, 2002
- Se-Methylselenocysteine: A New Compound for Chemoprevention of Breast CancerNutrition and Cancer, 2001
- Agents, biomarkers, and cohorts for chemopreventive agent development in prostate cancerUrology, 2001
- SUCCESSFUL AND NOT SO SUCCESSFUL CHEMOPREVENTION OF TOBACCO SMOKE-INDUCED LUNG TUMORSExperimental Lung Research, 2000
- Selenium in health and disease: A reviewCritical Reviews in Food Science and Nutrition, 1997
- Conventional cell culture media do not adequately supply cells with antioxidants and thus facilitate peroxide-induced genotoxicityFree Radical Biology & Medicine, 1996
- Selenium-mediated inhibition of transcription factor NF-κ B and HIV-1 LTR promoter activityArchives of Toxicology, 1996
- Selenium enhances glutathione peroxidase activity and prostacyclin release in cultured human endothelial cellsBiological Trace Element Research, 1994
- Oxidation of L-thiazolidine-4-carboxylate by L-proline dehydrogenase in Escherichia coliJournal of General Microbiology, 1992
- Prodrugs of L-cysteine as liver-protective agents. 2(R,S)-methylthiazolidine-4(R)-carboxylic acid (MTCA), a latent cysteineJournal of Medicinal Chemistry, 1982